RXi Pharma In Process Of Exploring Strategic Options - Quick Facts

(RTTNews) - RXi Pharmaceuticals Corp. (RXII) announced it is in the process of exploring strategic options including a range of potential M&A and business development opportunities. The company has engaged Griffin Securities, Inc. for one of these transactions.

"Following our recent reverse stock split and the full conversion of our preferred stock at the end of 2015, we have successfully reset the company's capital structure and are now better positioned to execute on one or more strategic transactions that would significantly advance our company," said Geert Cauwenbergh, President and CEO.